EDGAR Filing Documents for 0001214659-17-002138

Form 8-K - Current report:

SEC Accession No. 0001214659-17-002138

Filing Date

2017-03-23

Accepted

2017-03-23 16:15:22

Documents

Period of Report

2017-03-21

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		p3231708k.htm	8-K	33925
2	EXHIBIT 10.1	ex10_1.htm	EX-10.1	49936
3	EXHIBIT 10.2	ex10_2.htm	EX-10.2	18285
4	EXHIBIT 10.3	ex10_3.htm	EX-10.3	18411
5	EXHIBIT 10.4	ex10_4.htm	EX-10.4	18927
6	EXHIBIT 10.5	ex10_5.htm	EX-10.5	18602
7	EXHIBIT 99.1	ex99_1.htm	EX-99.1	10681
8		kalobios_logo.jpg	GRAPHIC	12812
	Complete submission text file	0001214659-17-002138.txt		187817

Mailing Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878

Business Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878 650.243.3100

KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)